Mechanism of the anti-tumour effect of 2,3,5-trimethyl-6-(3-pyridylmethyl) I ,4-benzoquinone (CV-6504)
1997

Anti-tumour effect of CV-6504

Sample size: 9 publication Evidence: moderate

Author Information

Author(s): HJ Hussey, MJ Tisdale

Primary Institution: Pharmaceutical Sciences Institute, Aston University

Hypothesis

CV-6504 inhibits the metabolism of arachidonic acid through lipoxygenase pathways to suppress tumor growth.

Conclusion

CV-6504 effectively reduces tumor growth and cachexia in mice by inhibiting fatty acid metabolism.

Supporting Evidence

  • CV-6504 reduced tumor volume and cachexia in mice.
  • CV-6504 inhibited the conversion of arachidonic acid to lipoxygenase metabolites in sensitive cell lines.
  • Different cell lines showed varying sensitivity to CV-6504 based on their fatty acid requirements.

Takeaway

CV-6504 is a medicine that helps stop tumors from growing by blocking certain fats that the tumors need.

Methodology

The study involved administering CV-6504 to mice with MAC16 tumors and analyzing tumor growth and fatty acid metabolism.

Limitations

The study was conducted on a limited number of cell lines and animal models.

Participant Demographics

Female NMRI mice were used in the study.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication